Epigral Limited — Others, 26-12-2024: Trading Window

Epigral has announced a board meeting to approve the financial results for the quarter and nine months ending December 31, 2024. During this period, the Trading Window will be closed for all insiders, directors, promoters, and designated persons, restricting any trading activity until 48 hours following the results declaration. This move is likely aimed at preventing insider trading ahead of the financial disclosures, reflecting a commitment to compliance and governance. Investors may view this as a sign of the company's proactive approach to transparency, potentially fostering a positive outlook among stakeholders.